Infection assay kit

geneticfor neutralizing antibodyvirus

The Diacegene SARS-CoV-2 Neutralizing Antibody Assay Kit (Immunofluorescence) is used as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection, it should not be used to diagnose acute SARS-CoV-2 infection. About SARS-CoV-2 Neutralizing Antibodies Infection by the SARS-CoV-2 or immunized by vaccine against SARS-CoV-2 will induce immune responses, such as the production of antibodies in the blood. These antibodies can specifically bind with virus receptor binding domain (RBD) to block the binding of RBD with ACE2 on human cells surface, thus prevent the virus or its genetic material into the human cell and virus infection. These antibodies are named neutralizing antibodies. The SARS-CoV-2 neutralizing antibodies are protective antibody produced by the human body after inoculation with novel coronavirus vaccine or infection with novel coronavirus. The kit is used to monitor the presence of neutralizing antibodies in subjects vaccinated with the novel coronavirus vaccine or in people infected with the novel coronavirus, it can be used to evaluate the immune effect after vaccination or whether neutralizing antibodies are produced in human body after infection with novel coronavirus, it should not be used to diagnose acute SARS-CoV-2 infection. Applicable Instrument: Immunofluorescent Analyzer (IFP-3000), Immunofluorescent Analyzer (IFP-2000) produced by Sichuan Xincheng Biological Co., Ltd.